Outset Medical, Inc.
No enriched coverage for $OM in the last 7 days.
No SEC Form 4 filings for $OM in the last 30 days.
Outset Medical, Inc. reported its financial results for the first quarter of 2026, showing a 6% decrease in revenue to $27.9 million compared to Q1 2025. Despite the revenue drop, the company improved its gross profit and gross margin, and reduced its net loss. Outset Medical reiterated its 2026 revenue guidance, projecting a 5% to 9% increase over 2025.
Outset Medical Inc. (OM) reported its Q1 earnings, missing the Estimated Price per Share (EPS) by $0.83. The company announced revenues of $27.9 million for the quarter. This report provides key financial figures for investors tracking OM's performance.
This article states that Outset Medical's (OM) price target has been decreased by 14.29% to 9.18. No further details are provided regarding the reasons for this change or the involved analysts.
